- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Therapeutic Nuclear Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Therapeutic Nuclear Medicines size is estimated to be xx million in 2021 from USD 1172 million in 2020, with a change of XX% between 2020 and 2021. The global Therapeutic Nuclear Medicines market size is expected to grow at a CAGR of 13.2% for the next five years.
Market segmentation
Therapeutic Nuclear Medicines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other
Market segment by Application can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other
The key market players for global Therapeutic Nuclear Medicines market are listed below:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines in 2018 and 2019.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Therapeutic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Nuclear Medicines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Nuclear Medicines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Nuclear Medicines Market Size & Forecast
1.4.1 Global Therapeutic Nuclear Medicines Sales in Value (2016-2026))
1.4.2 Global Therapeutic Nuclear Medicines Sales in Volume (2016-2026)
1.4.3 Global Therapeutic Nuclear Medicines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Therapeutic Nuclear Medicines Production Capacity Analysis
1.5.1 Global Therapeutic Nuclear Medicines Total Production Capacity (2016-2026)
1.5.2 Global Therapeutic Nuclear Medicines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Nuclear Medicines Market Drivers
1.6.2 Therapeutic Nuclear Medicines Market Restraints
1.6.3 Therapeutic Nuclear Medicines Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Therapeutic Nuclear Medicines Product and Services
2.1.4 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Therapeutic Nuclear Medicines Product and Services
2.2.4 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 China Isotope & Radiation
2.3.1 China Isotope & Radiation Details
2.3.2 China Isotope & Radiation Major Business
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
2.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Q BioMed
2.4.1 Q BioMed Details
2.4.2 Q BioMed Major Business
2.4.3 Q BioMed Therapeutic Nuclear Medicines Product and Services
2.4.4 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Curium Pharmaceuticals
2.5.1 Curium Pharmaceuticals Details
2.5.2 Curium Pharmaceuticals Major Business
2.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
2.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Jubilant DraxImage
2.6.1 Jubilant DraxImage Details
2.6.2 Jubilant DraxImage Major Business
2.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
2.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Dongcheng
2.7.1 Dongcheng Details
2.7.2 Dongcheng Major Business
2.7.3 Dongcheng Therapeutic Nuclear Medicines Product and Services
2.7.4 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Therapeutic Nuclear Medicines Product and Services
2.8.4 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Acrotech Biopharma.
2.9.1 Acrotech Biopharma. Details
2.9.2 Acrotech Biopharma. Major Business
2.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
2.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Progenics Pharmaceuticals
2.10.1 Progenics Pharmaceuticals Details
2.10.2 Progenics Pharmaceuticals Major Business
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
2.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business
2.11.3 International Isotopes Therapeutic Nuclear Medicines Product and Services
2.11.4 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Therapeutic Nuclear Medicines Sales by Manufacturer
3.1 Global Therapeutic Nuclear Medicines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Therapeutic Nuclear Medicines
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share
3.4.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share
3.5 Global Therapeutic Nuclear Medicines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Therapeutic Nuclear Medicines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Nuclear Medicines Market Size by Region
4.1.1 Global Therapeutic Nuclear Medicines Sales in Volume by Region (2016-2026)
4.1.2 Global Therapeutic Nuclear Medicines Revenue by Region (2016-2026)
4.2 North America Therapeutic Nuclear Medicines Revenue (2016-2026)
4.3 Europe Therapeutic Nuclear Medicines Revenue (2016-2026)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Revenue (2016-2026)
4.5 South America Therapeutic Nuclear Medicines Revenue (2016-2026)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Therapeutic Nuclear Medicines Sales in Volume by Type (2016-2026)
5.2 Global Therapeutic Nuclear Medicines Revenue by Type (2016-2026)
5.3 Global Therapeutic Nuclear Medicines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Therapeutic Nuclear Medicines Sales in Volume by Application (2016-2026)
6.2 Global Therapeutic Nuclear Medicines Revenue by Application (2016-2026)
6.3 Global Therapeutic Nuclear Medicines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Nuclear Medicines Sales by Type (2016-2026)
7.2 North America Therapeutic Nuclear Medicines Sales by Application (2016-2026)
7.3 North America Therapeutic Nuclear Medicines Market Size by Country
7.3.1 North America Therapeutic Nuclear Medicines Sales in Volume by Country (2016-2026)
7.3.2 North America Therapeutic Nuclear Medicines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Nuclear Medicines Sales by Type (2016-2026)
8.2 Europe Therapeutic Nuclear Medicines Sales by Application (2016-2026)
8.3 Europe Therapeutic Nuclear Medicines Market Size by Country
8.3.1 Europe Therapeutic Nuclear Medicines Sales in Volume by Country (2016-2026)
8.3.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Therapeutic Nuclear Medicines Sales by Type (2016-2026)
9.2 Asia-Pacific Therapeutic Nuclear Medicines Sales by Application (2016-2026)
9.3 Asia-Pacific Therapeutic Nuclear Medicines Market Size by Region
9.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Therapeutic Nuclear Medicines Sales by Type (2016-2026)
10.2 South America Therapeutic Nuclear Medicines Sales by Application (2016-2026)
10.3 South America Therapeutic Nuclear Medicines Market Size by Country
10.3.1 South America Therapeutic Nuclear Medicines Sales in Volume by Country (2016-2026)
10.3.2 South America Therapeutic Nuclear Medicines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2016-2026)
11.2 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2016-2026)
11.3 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Country
11.3.1 Middle East & Africa Therapeutic Nuclear Medicines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Therapeutic Nuclear Medicines Typical Distributors
12.3 Therapeutic Nuclear Medicines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Nuclear Medicines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Therapeutic Nuclear Medicines Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Therapeutic Nuclear Medicines Product and Services
Table 6. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Therapeutic Nuclear Medicines Product and Services
Table 10. Bayer Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 12. China Isotope & Radiation Major Business
Table 13. China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
Table 14. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 16. Q BioMed Major Business
Table 17. Q BioMed Therapeutic Nuclear Medicines Product and Services
Table 18. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Curium Pharmaceuticals Major Business
Table 21. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 22. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 24. Jubilant DraxImage Major Business
Table 25. Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
Table 26. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 28. Dongcheng Major Business
Table 29. Dongcheng Therapeutic Nuclear Medicines Product and Services
Table 30. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lantheus Basic Information, Manufacturing Base and Competitors
Table 32. Lantheus Major Business
Table 33. Lantheus Therapeutic Nuclear Medicines Product and Services
Table 34. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Acrotech Biopharma. Basic Information, Manufacturing Base and Competitors
Table 36. Acrotech Biopharma. Major Business
Table 37. Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
Table 38. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Progenics Pharmaceuticals Major Business
Table 41. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 42. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 44. International Isotopes Major Business
Table 45. International Isotopes Therapeutic Nuclear Medicines Product and Services
Table 46. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Therapeutic Nuclear Medicines Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Therapeutic Nuclear Medicines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Therapeutic Nuclear Medicines Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Therapeutic Nuclear Medicines Production Site of Key Manufacturer
Table 52. Therapeutic Nuclear Medicines New Entrant and Capacity Expansion Plans
Table 53. Therapeutic Nuclear Medicines Mergers & Acquisitions in the Past Five Years
Table 54. Global Therapeutic Nuclear Medicines Sales by Region (2016-2021e) & (K Units)
Table 55. Global Therapeutic Nuclear Medicines Sales by Region (2021-2026) & (K Units)
Table 56. Global Therapeutic Nuclear Medicines Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Therapeutic Nuclear Medicines Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Therapeutic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 59. Global Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 60. Global Therapeutic Nuclear Medicines Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Therapeutic Nuclear Medicines Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Therapeutic Nuclear Medicines Price by Type (2016-2021e) & (USD/Unit)
Table 63. Global Therapeutic Nuclear Medicines Price by Type (2021-2026) & (USD/Unit)
Table 64. Global Therapeutic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 65. Global Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 66. Global Therapeutic Nuclear Medicines Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Therapeutic Nuclear Medicines Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Therapeutic Nuclear Medicines Price by Application (2016-2021e) & (USD/Unit)
Table 69. Global Therapeutic Nuclear Medicines Price by Application (2021-2026) & (USD/Unit)
Table 70. North America Therapeutic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 71. North America Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 72. North America Therapeutic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Therapeutic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Therapeutic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 75. North America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 76. North America Therapeutic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 77. North America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 78. Europe Therapeutic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 80. Europe Therapeutic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Therapeutic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Therapeutic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 84. Europe Therapeutic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Therapeutic Nuclear Medicines Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Therapeutic Nuclear Medicines Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Therapeutic Nuclear Medicines Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Therapeutic Nuclear Medicines Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Therapeutic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Therapeutic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 94. South America Therapeutic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 95. South America Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 96. South America Therapeutic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Therapeutic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Therapeutic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 99. South America Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 100. South America Therapeutic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 101. South America Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Therapeutic Nuclear Medicines Typical Distributors
Table 113. Therapeutic Nuclear Medicines Typical Customers
List of Figures
Figure 1. Therapeutic Nuclear Medicines Picture
Figure 2. Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2020
Figure 3. Radium-223
Figure 4. Lutetium-177
Figure 5. Iodine-131
Figure 6. Other
Figure 7. Global Therapeutic Nuclear Medicines Sales Market Share by Application in 2020
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global Therapeutic Nuclear Medicines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Therapeutic Nuclear Medicines Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Therapeutic Nuclear Medicines Sales (2016-2026) & (K Units)
Figure 15. Global Therapeutic Nuclear Medicines Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Therapeutic Nuclear Medicines Production Capacity (2016-2026) & (K Units)
Figure 17. Global Therapeutic Nuclear Medicines Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Therapeutic Nuclear Medicines Market Drivers
Figure 19. Therapeutic Nuclear Medicines Market Restraints
Figure 20. Therapeutic Nuclear Medicines Market Trends
Figure 21. Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturer in 2020
Figure 22. Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturer in 2020
Figure 23. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2026)
Figure 27. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2026)
Figure 28. North America Therapeutic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 29. Europe Therapeutic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Therapeutic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 31. South America Therapeutic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Therapeutic Nuclear Medicines Revenue (2016-2026) & (USD Million)
Figure 33. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 34. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2016-2026)
Figure 35. Global Therapeutic Nuclear Medicines Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 37. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2016-2026)
Figure 38. Global Therapeutic Nuclear Medicines Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 40. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 41. North America Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 42. North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 43. United States Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 47. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 48. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 49. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 50. Germany Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region (2016-2026)
Figure 59. China Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 66. South America Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 67. South America Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 68. South America Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
